CN103305591B - 一种类凝血酶效价测定方法 - Google Patents
一种类凝血酶效价测定方法 Download PDFInfo
- Publication number
- CN103305591B CN103305591B CN201210056169.XA CN201210056169A CN103305591B CN 103305591 B CN103305591 B CN 103305591B CN 201210056169 A CN201210056169 A CN 201210056169A CN 103305591 B CN103305591 B CN 103305591B
- Authority
- CN
- China
- Prior art keywords
- thrombin
- enzyme
- blood coagulation
- plasma
- titer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 101000772006 Bombus ignitus Venom serine protease Bi-VSP Proteins 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 36
- 230000023555 blood coagulation Effects 0.000 claims abstract description 25
- 238000003908 quality control method Methods 0.000 claims abstract description 14
- 239000000758 substrate Substances 0.000 claims abstract description 6
- 210000002381 plasma Anatomy 0.000 claims description 24
- 238000012360 testing method Methods 0.000 claims description 15
- 239000003998 snake venom Substances 0.000 claims description 8
- 108090000190 Thrombin Proteins 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 238000010812 external standard method Methods 0.000 claims description 4
- 229960004072 thrombin Drugs 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000000413 hydrolysate Substances 0.000 claims description 2
- 229940080930 mannitol 50 mg/ml Drugs 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 7
- 102000009123 Fibrin Human genes 0.000 abstract description 2
- 108010073385 Fibrin Proteins 0.000 abstract description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract description 2
- 108010049003 Fibrinogen Proteins 0.000 abstract description 2
- 102000008946 Fibrinogen Human genes 0.000 abstract description 2
- 229950003499 fibrin Drugs 0.000 abstract description 2
- 229940012952 fibrinogen Drugs 0.000 abstract description 2
- 230000015271 coagulation Effects 0.000 abstract 2
- 238000005345 coagulation Methods 0.000 abstract 2
- 239000000126 substance Substances 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 108010027612 Batroxobin Proteins 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 239000002874 hemostatic agent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 229940030225 antihemorrhagics Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 108010065152 Coagulase Proteins 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241000271037 Crotalinae Species 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241001474977 Palla Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 241000271897 Viperidae Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- -1 arginine ester Chemical class 0.000 description 1
- 229960002210 batroxobin Drugs 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210056169.XA CN103305591B (zh) | 2012-03-06 | 2012-03-06 | 一种类凝血酶效价测定方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210056169.XA CN103305591B (zh) | 2012-03-06 | 2012-03-06 | 一种类凝血酶效价测定方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103305591A CN103305591A (zh) | 2013-09-18 |
CN103305591B true CN103305591B (zh) | 2014-07-30 |
Family
ID=49131309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210056169.XA Active CN103305591B (zh) | 2012-03-06 | 2012-03-06 | 一种类凝血酶效价测定方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103305591B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103604766A (zh) * | 2013-11-25 | 2014-02-26 | 牡丹江友搏药业股份有限公司 | 一种疏血通注射液的生物学质控方法 |
CN103884662B (zh) * | 2014-02-24 | 2017-01-11 | 辽宁诺康生物制药有限责任公司 | 一种测定类凝血酶活性的方法 |
CN114034655A (zh) * | 2021-10-20 | 2022-02-11 | 北京赛升药业股份有限公司 | 一种检测降纤酶原料及其制剂的活性的方法及应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1436304A (zh) * | 2000-06-09 | 2003-08-13 | 希莫斯科普公司 | 用于监测抗血小板制剂的方法和装置 |
CN1784604A (zh) * | 2003-03-07 | 2006-06-07 | 希莫斯科普公司 | 监测血小板抑制的方案 |
CN101983338A (zh) * | 2008-03-31 | 2011-03-02 | 希森美康株式会社 | 凝血分析仪、凝血分析方法及计算机程序 |
-
2012
- 2012-03-06 CN CN201210056169.XA patent/CN103305591B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1436304A (zh) * | 2000-06-09 | 2003-08-13 | 希莫斯科普公司 | 用于监测抗血小板制剂的方法和装置 |
CN1784604A (zh) * | 2003-03-07 | 2006-06-07 | 希莫斯科普公司 | 监测血小板抑制的方案 |
CN101983338A (zh) * | 2008-03-31 | 2011-03-02 | 希森美康株式会社 | 凝血分析仪、凝血分析方法及计算机程序 |
Non-Patent Citations (6)
Title |
---|
周立红 等.《血浆中纤维蛋白原的检测及临床意义》.《血栓与止血学杂志》.1998,第5卷(第4期),全文. * |
唐松山 等.《类凝血酶Agacutin的质量标准的研究》.《贵州大学学报》.2009,第26卷(第6期),全文. * |
胡慧珍,董淑清.《蛇毒类凝血酶的研究进展》.《当代畜禽养殖业》.2009,(第9期),全文. * |
薛雁等.《蛇毒类凝血酶的研究进展》.《蛇志》.2009,第21卷(第2期),全文. * |
齐元麟 等.《蕲蛇酶、凝血酶对人及牛纤维蛋白原的凝血反应比较》.《蛇志》.2000,第12卷(第2期),第1.1至1.2节,"讨论"部分. |
齐元麟 等.《蕲蛇酶、凝血酶对人及牛纤维蛋白原的凝血反应比较》.《蛇志》.2000,第12卷(第2期),第1.1至1.2节,"讨论"部分. * |
Also Published As
Publication number | Publication date |
---|---|
CN103305591A (zh) | 2013-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109884326B (zh) | 血小板聚集功能检测试剂盒 | |
CN103305591B (zh) | 一种类凝血酶效价测定方法 | |
ES2725426T3 (es) | Medios y procedimientos para calibración universal de pruebas anti-factor Xa | |
CN104048931A (zh) | 一种肝素含量的检测方法 | |
BR112014031934B1 (pt) | método com base em euglobulina para determinar a atividade biológica de defibrotide | |
JP2012516993A (ja) | 凍結乾燥ダビガトラン | |
Monib et al. | Inflammatory markers in acne vulgaris: Saliva as a novel diagnostic fluid | |
CN104049089B (zh) | 一种检测纤维蛋白原的方法及试剂盒 | |
CN105368915A (zh) | 凝血酶原时间测定试剂盒及其制备方法 | |
PT1456404E (pt) | Método para determinação da actividade biológica de defibrotida | |
CN109613128A (zh) | 一种法莫替丁胶囊中主药含量的测定方法 | |
CN103389385A (zh) | 一种乳胶包被的肌钙蛋白检测试剂盒 | |
CN102645414B (zh) | 测定尿液肌醇的试剂盒 | |
CN105368916A (zh) | 一种凝血酶原时间测定试剂盒及其制备方法 | |
CN106645751B (zh) | 一种纤维蛋白原含量检测试剂盒 | |
CN103592303A (zh) | 一种疏血通注射液的抗凝血酶活性测定方法 | |
CN111175515B (zh) | 一种血清淀粉样蛋白a和c反应蛋白的二合一质控物及其制备方法 | |
CN108593646A (zh) | 一种复方甘露醇注射液中间体甘露醇含量的快速检测方法 | |
CN114875114A (zh) | 一种可溶性fms样酪氨酸激酶-1质控品及其制备方法 | |
Matthews et al. | Capillary and venous blood glucose measurements using a direct glucose‐sensing meter | |
CN106198993A (zh) | 一种降钙素原蛋白的测定试剂及其制备方法 | |
CN109991218A (zh) | 一种凝固酶检测试纸的制备方法 | |
Chen et al. | The accuracy evaluation of four blood glucose monitoring systems according to ISO 15197: 2003 and ISO 15197: 2013 criteria | |
Sulik et al. | Preanalytical factors affecting the stability of matrix metalloproteinase-2 concentrations in cerebrospinal fluid | |
Vijayasamundeeswari et al. | Comparison of electrolyte levels in serum and plasma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 110171 Liaoning Province, Shenyang Hunnan New District Nanping Road No. 18 Patentee after: LIAONING GRAND NUOKANG BIOPHARMACEUTICAL CO.,LTD. Address before: 110171 Liaoning Province, Shenyang Hunnan New District Nanping Road No. 18 Patentee before: Liaoning Nuokang Biopharmaceutical Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |
Address after: 110171 Liaoning province Shenyang Hunnan Nanping Road No. 18-1 Patentee after: LIAONING GRAND NUOKANG BIOPHARMACEUTICAL CO.,LTD. Address before: 110171 Liaoning Province, Shenyang Hunnan New District Nanping Road No. 18 Patentee before: LIAONING GRAND NUOKANG BIOPHARMACEUTICAL CO.,LTD. |
|
CP02 | Change in the address of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: No.18-1, Nanping East Road, Hunnan New District, Shenyang City, Liaoning Province Patentee after: Yuanda Life Science (Liaoning) Co.,Ltd. Address before: No.18-1, Nanping East Road, Hunnan New District, Shenyang City, Liaoning Province Patentee before: LIAONING GRAND NUOKANG BIOPHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for determination of thrombin titer Effective date of registration: 20220517 Granted publication date: 20140730 Pledgee: Bank of China Limited Shenyang Tiexi sub branch Pledgor: Yuanda Life Science (Liaoning) Co.,Ltd. Registration number: Y2022210000044 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230815 Granted publication date: 20140730 Pledgee: Bank of China Limited Shenyang Tiexi sub branch Pledgor: Yuanda Life Science (Liaoning) Co.,Ltd. Registration number: Y2022210000044 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |